Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder

Immunology and Allergy Clinics of North America
Patrizia Bonadonna, Luigi Scaffidi

Abstract

Up to 7% of adult patients with Hymenoptera venom allergy may suffer from a clonal mast cell disease. Patients with clonal mast cell disease and Hymenoptera venom anaphylaxis are commonly males, without skin lesions, and anaphylaxis is characterized by hypotension and syncope in the absence of urticaria and angioedema. A normal value of tryptase does not exclude a mastocytosis. The diagnosis of a mast cell disease leads to several therapeutic consequences concerning the treatment of Hymenoptera venom allergy as matter of fact these patients have to undergo long-life venom immunotherapy, to prevent further, potentially fatal severe reactions.

Citations

Nov 6, 2018·Allergy·Amy WilcockPeter D Arkwright
Jul 26, 2019·Current Opinion in Allergy and Clinical Immunology·Maria B BilòSimon Blank
Jul 2, 2019·Current Opinion in Allergy and Clinical Immunology·Iván Alvarez-Twose, Almudena Matito
Jul 16, 2019·Current Opinion in Allergy and Clinical Immunology·Patrizia BonadonnaElisa Boni
Mar 19, 2019·Expert Review of Clinical Immunology·Theoharis C TheoharidesHuali Ren
Jan 11, 2020·Frontiers in Immunology·Mamidipudi Thirumala KrishnaMaria Beatrice Bilo
Jul 26, 2019·Case Reports in Medicine·D ForlaniM Di Gioacchino
Jan 26, 2021·American Journal of Clinical Dermatology·Julie V Schaffer
Jan 15, 2021·Vaccines·Marco CaminatiGianenrico Senna
Mar 3, 2021·Human Vaccines & Immunotherapeutics·Ali Selcuk, Abdullah Baysan
Apr 8, 2021·Current Allergy and Asthma Reports·Irene MikhailBenjamin T Prince
Jul 28, 2020·La Revue de médecine interne·H LobbesS Durupt
Mar 23, 2021·The Journal of Allergy and Clinical Immunology·Jason GotlibCem Akin
May 1, 2021·Journal of Clinical Medicine·Roberta ZanottiPatrizia Bonadonna
May 12, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Leander P De PuysseleyrVito Sabato

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Related Papers

Current Allergy and Asthma Reports
Patrizia BonadonnaRoberta Zanotti
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
Gabrielle HaeberliU Müller
Current Opinion in Allergy and Clinical Immunology
F RuëffBernhard Przybilla
Current Allergy and Asthma Reports
Patrizia BonadonnaRoberta Zanotti
© 2022 Meta ULC. All rights reserved